Literature DB >> 33664896

The challenge of optimising ablation lesions in catheter ablation of ventricular tachycardia.

Riccardo Proietti1,2, Luca Lichelli2, Nicolas Lellouche3,4, Tarvinder Dhanjal1,5.   

Abstract

Radiofrequency catheter ablation has become an established treatment for ventricular tachycardia. The exponential increase in procedures has provided further insights into mechanisms causing arrhythmias and identification of ablation targets with the development of new mapping strategies. Since the definition of criteria to identify myocardial dense scar, borderzone and normal myocardium, and the description of isolated late potentials, local abnormal ventricular activity and decrementing evoked potential mapping, substrate-guided ablation has progressively become the method of choice to guide procedures. Accordingly, a wide range of ablation strategies have been developed from scar homogenization to scar dechanneling or core isolation using increasingly complex and precise tools such as multipolar or omnipolar mapping catheters. Despite these advances long-term success rates for VT ablation have remained static and lower in nonischemic than ischemic heart disease because of the more patchy distribution of myocardial scar. Ablation aims to deliver an irreversible loss of cellular excitability by myocardial heating to a temperatures exceeding 50°C. Many indicators of ablation efficacy have been developed such as contact force, impedance drop, force-time integral and ablation index, mostly validated in atrial fibrillation ablation. In ventricular procedures there is limited data and ablation lesion parameters have been scarcely investigated. Since VT arrhythmia recurrence can be related to inadequate RF lesion formation, it seems reasonable to establish robust markers of ablation efficacy.
© 2020 The Authors. Journal of Arrhythmia published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Heart Rhythm Society.

Entities:  

Keywords:  catheter ablation; long‐term outcome; multipolar mapping; omnipolar mapping; ventricular tachycardia

Year:  2020        PMID: 33664896      PMCID: PMC7896466          DOI: 10.1002/joa3.12489

Source DB:  PubMed          Journal:  J Arrhythm        ISSN: 1880-4276


  70 in total

1.  Electrocardiographic recognition of the epicardial origin of ventricular tachycardias.

Authors:  Antonio Berruezo; Lluis Mont; Santiago Nava; Enrique Chueca; Eduardo Bartholomay; Josep Brugada
Journal:  Circulation       Date:  2004-04-12       Impact factor: 29.690

2.  Characterization of acute and subacute radiofrequency ablation lesions with nonenhanced magnetic resonance imaging.

Authors:  Timm Dickfeld; Ritsushi Kato; Menekem Zviman; Saman Nazarian; Jun Dong; Hiroshi Ashikaga; Albert C Lardo; Ronald D Berger; Hugh Calkins; Henry Halperin
Journal:  Heart Rhythm       Date:  2006-11-01       Impact factor: 6.343

3.  Feasibility of contrast-enhanced and nonenhanced MRI for intraprocedural and postprocedural lesion visualization in interventional electrophysiology: animal studies and early delineation of isthmus ablation lesions in patients with typical atrial flutter.

Authors:  Peter Nordbeck; Karl-Heinz Hiller; Florian Fidler; Marcus Warmuth; Natalie Burkard; Matthias Nahrendorf; Peter M Jakob; Harald H Quick; Georg Ertl; Wolfgang R Bauer; Oliver Ritter
Journal:  Circ Cardiovasc Imaging       Date:  2011-03-17       Impact factor: 7.792

4.  Catheter ablation in patients with multiple and unstable ventricular tachycardias after myocardial infarction: short ablation lines guided by reentry circuit isthmuses and sinus rhythm mapping.

Authors:  K Soejima; M Suzuki; W H Maisel; C B Brunckhorst; E Delacretaz; L Blier; S Tung; H Khan; W G Stevenson
Journal:  Circulation       Date:  2001-08-07       Impact factor: 29.690

5.  Relationship between successful ablation sites and the scar border zone defined by substrate mapping for ventricular tachycardia post-myocardial infarction.

Authors:  Atul Verma; Nassir F Marrouche; Robert A Schweikert; Walid Saliba; Oussama Wazni; Jennifer Cummings; Ahmad Abdul-Karim; Mandeep Bhargava; J David Burkhardt; Fethi Kilicaslan; David O Martin; Andrea Natale
Journal:  J Cardiovasc Electrophysiol       Date:  2005-05

6.  Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study.

Authors:  Borislav Dinov; Lukas Fiedler; Robert Schönbauer; Andreas Bollmann; Sascha Rolf; Christopher Piorkowski; Gerhard Hindricks; Arash Arya
Journal:  Circulation       Date:  2013-11-08       Impact factor: 29.690

7.  Characteristics of the ablation lesions in cardiac magnetic resonance imaging after radiofrequency ablation of ventricular arrhythmias in relation to the procedural success.

Authors:  Borislav Dinov; Sabrina Oebel; Sebastian Hilbert; Susanne Loebe; Arash Arya; Andreas Bollmann; Philipp Sommer; Cosima Jahnke; Ingo Paetsch; Gerhard Hindricks
Journal:  Am Heart J       Date:  2018-08-02       Impact factor: 4.749

8.  Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia.

Authors:  Henry H Hsia; David J Callans; Francis E Marchlinski
Journal:  Circulation       Date:  2003-07-28       Impact factor: 29.690

9.  Low contact force and force-time integral predict early recovery and dormant conduction revealed by adenosine after pulmonary vein isolation.

Authors:  Jean-Benoît le Polain de Waroux; Rukshen Weerasooriya; Kalilur Anvardeen; Cynthia Barbraud; Sebastien Marchandise; Christophe De Meester; Cedric Goesaert; Ivone Reis; Christophe Scavee
Journal:  Europace       Date:  2015-01-24       Impact factor: 5.214

10.  Massive Accumulation of Myofibroblasts in the Critical Isthmus Is Associated With Ventricular Tachycardia Inducibility in Post-Infarct Swine Heart.

Authors:  Tarvinder S Dhanjal; Nicolas Lellouche; Christopher J von Ruhland; Guillaume Abehsira; David H Edwards; Jean-Luc Dubois-Randé; Konstantinos Moschonas; Emmanuel Teiger; Alan J Williams; Christopher H George
Journal:  JACC Clin Electrophysiol       Date:  2017-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.